OSA and Recurrent VTE: Causality or Cause?
Sign Up to like & getrecommendations! Published in 2017 at "Chest"
DOI: 10.1016/j.chest.2016.10.063
Abstract: We wholeheartedly agree with Sharp and colleagues that cost saving is another potential benefit to transbronchial cryobiopsies in addition to safety and effectiveness.Welldesigned and conducted, randomized controlled studies are needed to better define the position… read more here.
Keywords: causality cause; recurrent vte; osa recurrent; vte causality ... See more keywords
Effectiveness and Safety of Apixaban versus Warfarin in Venous Thromboembolism Patients with Chronic Kidney Disease.
Sign Up to like & getrecommendations! Published in 2021 at "Thrombosis and haemostasis"
DOI: 10.1055/s-0041-1740254
Abstract: There has been limited evidence reported about the outcomes of oral anticoagulants among patients with venous thromboembolism (VTE) and chronic kidney disease (CKD), especially those with stage V/end-stage renal disease (ESRD). This retrospective cohort analysis… read more here.
Keywords: recurrent vte; versus warfarin; apixaban versus; disease ... See more keywords
P5593The association of recurrence and bleeding events with mortality after venous thromboembolism: from the COMMAND VTE Registry
Sign Up to like & getrecommendations! Published in 2019 at "European Heart Journal"
DOI: 10.1093/eurheartj/ehz746.0537
Abstract: Venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT), has a long-term risk for recurrence, which can be prevented by anticoagulation therapy. The duration of anticoagulation therapy after VTE should be based… read more here.
Keywords: vte; vte events; bleeding events; major bleeding ... See more keywords
Identification of outcomes in clinical studies of interventions for venous thromboembolism in non‐pregnant adults
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Thrombosis and Haemostasis"
DOI: 10.1111/jth.15849
Abstract: Hence, VTE is a major public health issue and public health agencies promote active research in VTE. However, despite major advances in the understanding of pathophysiology and treatment modalities, the prognosis of VTE has not… read more here.
Keywords: unprovoked vte; recurrent vte; anticoagulation; vte ... See more keywords
Venous Thromboembolism in Children 0-18 Years — a Regional Population-Based Study from Sweden
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-113844
Abstract: Introduction: Venous thromboembolism (VTE) is a rare complication in childhood. Pediatric VTE is an important and increasingly frequent clinical challenge likely due to increased detection and advanced medical interventions leading to improved survival of previously… read more here.
Keywords: vte; risk; study; risk factors ... See more keywords
Safe and Effective Use of Rivaroxaban for Treatment of Cancer Associated Venous Thromboembolic Disease
Sign Up to like & getrecommendations! Published in 2018 at "Blood"
DOI: 10.1182/blood-2018-99-115506
Abstract: Introduction: Venous thromboembolism (VTE) is a common complication of cancer, associated with significant morbidity and mortality. Low-molecular weight heparin (LMWH), the most widely used anticoagulant in this setting, is expensive and burdensome. Rivaroxaban (Riva) was… read more here.
Keywords: treatment; riva; recurrent vte; cat ... See more keywords
Risk Factors Associated with 6-Month Recurrent VTE Among Patients in Two Large Population-Based Surveillance Systems
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126903
Abstract: Introduction The incidence of recurrent venous thromboembolism (VTE), encompassing deep vein thrombosis (DVT) and pulmonary embolism (PE), is dependent on multiple patient demographic factors and medical co-morbidities, such as cancer and surgery. We sought to… read more here.
Keywords: vte; index; index vte; surveillance ... See more keywords
Safety and Effectiveness of Apixaban, LMWH and Warfarin Among Venous Thromboembolism (VTE) Patients with Active Cancer: A Subgroup Analysis of VTE Risk Scale
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-126931
Abstract: BACKGROUND: Cancer is an independent risk factor for venous thromboembolism (VTE) and the strongest predictor for all-cause and pulmonary embolism-related mortality. VTE risk is 4-7 times higher in cancer patients compared to non-cancer patients. Different… read more here.
Keywords: vte; risk; recurrent vte; vte risk ... See more keywords
Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study
Sign Up to like & getrecommendations! Published in 2019 at "Blood"
DOI: 10.1182/blood-2019-129087
Abstract: Introduction Venous thromboembolism (VTE) is a difficult to treat condition in patients with cancer with a persisting risk of recurrent VTE during anticoagulant treatment with low-molecular weight heparin (LMWH). Recent data suggest that direct oral… read more here.
Keywords: cancer; ottawa score; recurrent vte; research funding ... See more keywords